AAAAAA
Results: 1-25/32
Authors:
Langevitz, P
Livneh, A
Neumann, L
Buskila, D
Shemer, J
Amolsky, D
Pras, M
Citation: P. Langevitz et al., Prevalence of ischemic heart disease in patients with familial Mediterranean fever, ISR MED ASS, 3(1), 2001, pp. 9-12
Authors:
Apter, S
Zemer, D
Terhakopian, A
Gayer, G
Langevitz, P
Amitai, M
Schwartz, T
Atar, E
Hertz, M
Pras, M
Livneh, A
Citation: S. Apter et al., Abdominal CT findings in nephropathic amyloidosis of familial Mediterranean fever, AMYLOID, 8(1), 2001, pp. 58-64
Authors:
Livneh, A
Aksentijevich, I
Langevitz, P
Torosyna, Y
G-Shoham, N
Shinar, Y
Pras, E
Zaks, N
Padeh, S
Kastner, DL
Pras, M
Citation: A. Livneh et al., A single mutated MEFV allele in Israeli patients suffering from familial Mediterranean fever and Behcet's disease (FMF-BD), EUR J HUM G, 9(3), 2001, pp. 191-196
Authors:
Lidar, M
Braf, A
Givol, N
Langevitz, P
Pauzner, R
Many, A
Livneh, A
Citation: M. Lidar et al., Anti-insulin antibodies and the natural autoimmune response in systemic lupus erythematosus, LUPUS, 10(2), 2001, pp. 81-86
Authors:
Barash, J
Pirogovski, A
Livneh, A
Brezniak, N
Dror, Y
Hahn, T
Citation: J. Barash et al., Colchicine treatment in familial Mediterranean fever: An indirect effect on in vitro serum amyloid A secretion via leukocyte derived factors, CLIN EXP RH, 19(5), 2001, pp. S76-S76
Authors:
Kogan, A
Shinar, Y
Lidar, M
Revivo, A
Langevitz, P
Padeh, S
Pras, M
Livneh, A
Citation: A. Kogan et al., Common MEFV mutations among Jewish ethnic groups in Israel: High frequencyof carrier and phenotype III states and absence of a perceptible biological advantage for the carrier state, AM J MED G, 102(3), 2001, pp. 272-276
Authors:
Shtrasburg, S
Pras, M
Gal, R
Salai, M
Livneh, A
Citation: S. Shtrasburg et al., Inhibition of the second phase of amyloidogenesis in a mouse model by a single-dose colchicine regimen, J LA CL MED, 138(2), 2001, pp. 107-111
Authors:
Poland, DCW
Drenth, JPH
Rabinovitz, E
Livneh, A
Bijzet, J
Hof, BV
van Dijk, W
Citation: Dcw. Poland et al., Specific glycosylation of alpha(1)-acid glycoprotein characterises patients with familial Mediterranean fever and obligatory carriers of MEFV, ANN RHEUM D, 60(8), 2001, pp. 777-780
Authors:
Livneh, A
Langevitz, P
Citation: A. Livneh et P. Langevitz, Diagnostic and treatment concerns in familial Mediterranean fever, BEST PR R C, 14(3), 2000, pp. 477-498
Authors:
Sherer, Y
Livneh, A
Levy, Y
Shoenfeld, Y
Langevitz, P
Citation: Y. Sherer et al., Dermatomyositis and polymyositis associated with the antiphospholipid syndrome - a novel overlap syndrome, LUPUS, 9(1), 2000, pp. 42-46
Authors:
Livneh, A
Shtrasburg, S
Langevitz, P
Citation: A. Livneh et al., Regression of nephrotic syndrome in amyloidosis of familial Mediterranean fever following colchicine treatment, NEPH DIAL T, 15(10), 2000, pp. 1713-1714
Authors:
Shinar, Y
Livneh, A
Langevitz, P
Zaks, N
Aksentijevich, I
Koziol, DE
Kastner, DL
Pras, M
Pras, E
Citation: Y. Shinar et al., Genotype-phenotype assessment of common genotypes among patients with familial Mediterranean fever, J RHEUMATOL, 27(7), 2000, pp. 1703-1707
Authors:
Sidi, G
Shinar, Y
Livneh, A
Langevitz, P
Pras, M
Pras, E
Citation: G. Sidi et al., Protracted febrile myalgia of familial Mediterranean fever - Mutation analysis and clinical correlations, SC J RHEUM, 29(3), 2000, pp. 174-176
Authors:
Barzilai, A
Langevitz, P
Goldberg, I
Kopolovic, J
Livneh, A
Pras, M
Trau, H
Citation: A. Barzilai et al., Erysipelas-like erythema of familial Mediterranean fever: Clinicopathologic correlation, J AM ACAD D, 42(5), 2000, pp. 791-795
Authors:
Press, J
Shinar, Y
Langevitz, P
Livneh, A
Pras, M
Buskila, D
Citation: J. Press et al., Familial Mediterranean fever in two Bedouin families: Mutation analysis and disease severity, AM J MED G, 92(4), 2000, pp. 247-249
Authors:
Sherer, Y
Salomon, O
Livneh, A
Pras, M
Langevitz, P
Citation: Y. Sherer et al., Thromboembolism in a patient with transient eosinophilia and thrombocytopenia, CLIN LAB H, 22(4), 2000, pp. 247-249
Authors:
Langevitz, P
Livneh, A
Bank, I
Pras, M
Citation: P. Langevitz et al., Benefits and risks of minocycline in rheumatoid arthritis, DRUG SAFETY, 22(5), 2000, pp. 405-414
Authors:
Schwartz, T
Langevitz, P
Zemer, D
Gazit, E
Pras, M
Livneh, A
Citation: T. Schwartz et al., Behcet's disease in Familial Mediterranean Fever: Characterization of the association between the two diseases, SEM ARTH RH, 29(5), 2000, pp. 286-295
Authors:
Drenth, JPH
Livneh, A
Citation: Jph. Drenth et A. Livneh, Behcet's disease., N ENG J MED, 342(8), 2000, pp. 588-588
Authors:
Padeh, S
Brezniak, N
Zemer, D
Pras, E
Livneh, A
Langevitz, P
Migdal, A
Pras, M
Passwell, JH
Citation: S. Padeh et al., Hyper-IgD syndrome and familial Hibernian fever are true periodic fever syndromes - Reply, J PEDIAT, 137(3), 2000, pp. 439-440
Authors:
Shtrasburg, S
Pras, M
Dolitzky, M
Pariente, C
Gal, R
Livneh, A
Citation: S. Shtrasburg et al., Pregnancy and amyloidosis: II. Suppression of amyloidogenesis during pregnancy, J LA CL MED, 136(4), 2000, pp. 314-319
Authors:
Langevitz, P
Livneh, A
Padeh, S
Zaks, N
Shinar, Y
Zemer, D
Pras, E
Pras, M
Citation: P. Langevitz et al., Familial Mediterranean fever: New aspects and prospects at the end of the millenium, ISR MED ASS, 1(1), 1999, pp. 31-36
Authors:
Livneh, A
Langevitz, P
Shinar, Y
Zaks, N
Kastner, DL
Pras, M
Pras, E
Citation: A. Livneh et al., MEFV mutation analysis in patients suffering from amyloidosis of familial Mediterranean fever, AMYLOID, 6(1), 1999, pp. 1-6
Authors:
Amital, H
Langevitz, P
Levy, Y
Afek, A
Goldberg, I
Pras, M
Livneh, A
Shoenfeld, Y
Citation: H. Amital et al., Valvular deposition of antiphospholipid antibodies in the antiphospholipidsyndrome: A clue to the origin of the disease, CLIN EXP RH, 17(1), 1999, pp. 99-102
Authors:
Gang, N
Drenth, JPH
Langevitz, P
Zemer, D
Brezniak, N
Pras, M
van der Meer, JWM
Livneh, A
Citation: N. Gang et al., Activation of the cytokine network in familial Mediterranean fever, J RHEUMATOL, 26(4), 1999, pp. 890-897